CLINICAL GUIDELINE Clinical recommendations for perioperative immunotherapy- induced adverse events in patients with non-small cell lung cancer Jun Ni 1 | Miao Huang 2 | Li Zhang 1 | Nan Wu 2 | Chun-Xue Bai 3 | Liang-An Chen 4 | Jun Liang 5 | Qian Liu 6 | Jie Wang 7 | Yi-Long Wu 8 | Feng-Chun Zhang 1 | Shu-Yang Zhang 1 | Chun Chen 9 | Jun Chen 10 | Wen-Tao Fang 11 | Shu-Geng Gao 7 | Jian Hu 12 | Tao Jiang 13 | Shan-Qing Li 1 | He-Cheng Li 14 | Yong-De Liao 15 | Yang Liu 4 | De-Ruo Liu 16 | Hong-Xu Liu 17 | Jian-Yang Liu 18 | Lun-Xu Liu 19 | Meng-Zhao Wang 1 | Chang-Li Wang 20 | Fan Yang 21 | Yue Yang 2 | Lan-Jun Zhang 22 | Xiu-Yi Zhi 23 | Wen-Zhao Zhong 8 | Yu-Zhou Guan 1 | Xiao-Xiao Guo 1 | Chun-Xia He 1 | Shao-Lei Li 2 | Yue Li 1 | Nai-Xin Liang 1 | Fang-Liang Lu 2 | Chao Lv 2 | Wei Lv 1 | Xiao-Yan Si 1 | Feng-Wei Tan 7 | Han-Ping Wang 1 | Jiang-Shan Wang 1 | Shi Yan 2 | Hua-Xia Yang 1 | Hui-Juan Zhu 1 | Jun-Ling Zhuang 1 | Ming-Lei Zhuo 2 1 Peking Union Medical Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, China 2 Peking University Cancer Hospital, Beijing, China 3 Zhongshan Hospital, Fudan University, Shanghai, China 4 The First Medical Center of Chinese PLA General Hospital, Beijing, China 5 Peking University International Hospital, Beijing, China 6 Chinese Journal of Lung Cancer, Beijing, China 7 National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China 8 Guangdong Lung Cancer Institute, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China 9 Fujian Medical University Union Hospital, Fuzhou, China 10 Tianjin Medical University General Hospital, Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Tianjin Lung Cancer Institute, Tianjin, China 11 Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China 12 The First Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang, China 13 Tangdu Hospital, Fourth Military Medical University, Xi’an, China 14 Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China 15 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China 16 China-Japan Friendship Hospital, Beijing, China 17 Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang, China 18 Jilin Cancer Hospital, Changchun, China 19 West China Hospital, Sichuan University, Chengdu, China 20 National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China Jun Ni and Miao Huang contributed equally to the study. Received: 1 March 2021 Accepted: 3 March 2021 DOI: 10.1111/1759-7714.13942 This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. © 2021 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd. Thorac Cancer. 2021;12:1469–1488. wileyonlinelibrary.com/journal/tca 1469